209 related articles for article (PubMed ID: 8369526)
21. Prognostic value of DNA flow cytometry in the locally recurrent, conservatively treated breast cancer patient.
Haffty BG; Toth M; Flynn S; Fischer D; Carter D
J Clin Oncol; 1992 Dec; 10(12):1839-47. PubMed ID: 1453198
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of DNA ploidy, S-phase fraction, and P-glycoprotein expression in colorectal cancer.
Salud A; Porcel JM; Raikundalia B; Camplejohn RS; Taub NA
J Surg Oncol; 1999 Nov; 72(3):167-74. PubMed ID: 10562364
[TBL] [Abstract][Full Text] [Related]
23. DNA flow cytometric analysis and prognosis of axillary lymph node-negative breast carcinoma.
Bosari S; Lee AK; Tahan SR; Figoni MA; Wiley BD; Heatley GJ; Silverman ML
Cancer; 1992 Oct; 70(7):1943-50. PubMed ID: 1525770
[TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of ploidy and S-phase fraction in primary intraoral squamous cell carcinoma and their corresponding metastatic lymph nodes.
El-Deftar MF; El Gerzawi SM; Abdel-Azim AA; Tohamy SM
J Egypt Natl Canc Inst; 2012 Mar; 24(1):7-14. PubMed ID: 23587227
[TBL] [Abstract][Full Text] [Related]
25. DNA ploidy level and S-phase fraction as prognostic factors in breast cancer.
Yokoe T; Izuo M; Ishida T; Iino Y; Kawai T
Jpn J Surg; 1990 Sep; 20(5):491-7. PubMed ID: 2243441
[TBL] [Abstract][Full Text] [Related]
26. Tumour DNA ploidy as an independent prognostic factor in breast cancer.
Kallioniemi OP; Blanco G; Alavaikko M; Hietanen T; Mattila J; Lauslahti K; Koivula T
Br J Cancer; 1987 Nov; 56(5):637-42. PubMed ID: 3426929
[TBL] [Abstract][Full Text] [Related]
27. Prognostic comparative study of S-phase fraction and Ki-67 index in breast carcinoma.
Pinto AE; André S; Pereira T; Nóbrega S; Soares J
J Clin Pathol; 2001 Jul; 54(7):543-9. PubMed ID: 11429427
[TBL] [Abstract][Full Text] [Related]
28. DNA analysis in advanced breast cancer.
Leivonen M; Krogerus L; Nordling S
Cancer Detect Prev; 1994; 18(2):87-96. PubMed ID: 8025900
[TBL] [Abstract][Full Text] [Related]
29. DNA flow cytometry in surgically treated lung cancer--prognostic significance.
Ikonen JT; Ojala A; Salenius JP; Mattila J; Riekkinen H; Wigren T
Scand Cardiovasc J; 1999; 33(4):228-33. PubMed ID: 10517210
[TBL] [Abstract][Full Text] [Related]
30. Cell proliferation in ovarian carcinoma: superior accuracy of S-phase fraction (SPF) by DNA labeling index versus flow cytometric SPF, lack of independent prognostic power for SPF and DNA ploidy, and limited effect of SPF on tumor growth rate.
Meyer JS; Gersell DJ; Yim S
Gynecol Oncol; 2001 Jun; 81(3):466-76. PubMed ID: 11371140
[TBL] [Abstract][Full Text] [Related]
31. The prognostic information of DNA ploidy and S-phase fraction may vary with histologic grade in endometrial carcinoma.
Gudmundsson TE; Högberg T; Alm P; Anderson H; Baldetorp B; Fernö M; Långström E; Killander D
Acta Oncol; 1995; 34(6):803-12. PubMed ID: 7576749
[TBL] [Abstract][Full Text] [Related]
32. Prognostic impact of DNA ploidy pattern, S-phase fraction (SPF), and proliferating cell nuclear antigen (PCNA) in patients with primary gastric lymphoma.
Belessi CJ; Parasi AS; Manioudaki HS; Laoutaris NP; Legakis NC; Peros GT; Androulakis GA
J Surg Oncol; 2003 Apr; 82(4):247-55. PubMed ID: 12672009
[TBL] [Abstract][Full Text] [Related]
33. C-erbB-2 oncoprotein overexpression identifies a subgroup of estrogen receptor positive (ER+) breast cancer patients with poor prognosis.
Pinto AE; André S; Pereira T; Nóbrega S; Soares J
Ann Oncol; 2001 Apr; 12(4):525-33. PubMed ID: 11398888
[TBL] [Abstract][Full Text] [Related]
34. S-phase fraction and DNA ploidy in 633 T1T2 breast cancers: a standardized flow cytometric study.
Chassevent A; Jourdan ML; Romain S; Descotes F; Colonna M; Martin PM; Bolla M; Spyratos F
Clin Cancer Res; 2001 Apr; 7(4):909-17. PubMed ID: 11309341
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of DNA ploidy and S-phase fraction in stage I endometrial carcinoma.
Pfisterer J; Kommoss F; Sauerbrei W; Rendl I; Kiechle M; Kleine W; Pfleiderer A
Gynecol Oncol; 1995 Aug; 58(2):149-56. PubMed ID: 7622098
[TBL] [Abstract][Full Text] [Related]
36. Mammographic growth rate, DNA ploidy, and S-phase fraction analysis in breast carcinoma. A prognostic evaluation in a screened population.
Arnerlöv C; Emdin SO; Lundgren B; Roos G; Söderström J; Bjersing L; Norberg C; Angquist KA
Cancer; 1992 Oct; 70(7):1935-42. PubMed ID: 1525769
[TBL] [Abstract][Full Text] [Related]
37. DNA analysis of breast cancer by flow cytometry & correlation with other prognostic parameters.
Redkar AA; Balsara BR; Bhisey AN; Sampat MB; Mittra I
Indian J Med Res; 1992 Aug; 96():223-9. PubMed ID: 1428060
[TBL] [Abstract][Full Text] [Related]
38. Flow cytometric analysis of uterine sarcoma: ploidy and S-phase rate as prognostic indicators.
Malmström H; Schmidt H; Persson PG; Carstensen J; Nordenskjöld B; Simonsen E
Gynecol Oncol; 1992 Feb; 44(2):172-7. PubMed ID: 1544595
[TBL] [Abstract][Full Text] [Related]
39. Sex steroid receptors, S-phase fraction and DNA ploidy as determinants of the risk of relapse and death of female breast cancer.
Lipponen P; Eskelinen M; Papinaho S; Klemi PJ; Aaltomaa S; Kosma VM; Marin S; Syrjänen K
Anticancer Res; 1992; 12(3):677-82. PubMed ID: 1622125
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of morphological parameters and flow cytometric DNA analysis in carcinoma of the breast.
Visscher DW; Zarbo RJ; Greenawald KA; Crissman JD
Pathol Annu; 1990; 25 Pt 1():171-210. PubMed ID: 2153277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
